{
  "drug_name": "Bacitracin",
  "url": "https://wikem.org/wiki/Bacitracin",
  "scraped_at": "2026-01-10T07:48:25.566776",
  "sections": {
    "Administration": {
      "text": "Type: Topical\nantibiotic\nDosage Forms: ointment\nDosage strengths: 500 unit/g\nRoutes of Administration: topical, ophthalmic, IM\nCommon Trade Names:  BACiiM, Baciguent, Bacitracin Ophthalmic Ointment",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "antibiotic",
          "url": "https://wikem.org/wiki/Antibiotic"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "Apply to wound 2-5 times per day",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Apply to wound 2-5 times per day\nStaph pneumonia/empyema known to be susceptible to bacitracin: 900-1000 units/kg/day IM in 2 to 3 divided doses",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk\n: Infant risk minimal\nRenal: no adjustment\nHepatic: No adjustment",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Renal toxicity (IM only)",
          "tables": []
        },
        "Common": {
          "text": "Contact dermatitis",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Renal toxicity (IM only)",
      "subsections": {
        "Common": {
          "text": "Contact dermatitis",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Contact dermatitis",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life:\nMetabolism:\nExcretion: Urine 10-40%",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Interferes with cell wall peptidoglycan activity\nActive against staph",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "References": {
      "text": "BACiiM (bacitracin) [prescribing information], Horseheads, NY: X-Gen Pharmaceuticals Inc; June 2008.\nBacitracin (prescribing information). New York, NY: Pharmacia & Upjohn; September 2015.\nChia JK, Nakata MM, Park SS, et al, “Use of Bacitracin Therapy for Infection Due to Vancomycin-Resistant Enterococcus faecium,” Clin Infect Dis, 1995, 21(6):1520.  [PubMed 8749657]\nCohen SH, Gerding DN, Johnson S, et al, “Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for healthcare Epidemiology of American (SHEA) and the Infectious Diseases Society of America (IDSA), Infect Control Hosp Epidemiol, 2010, 31(5):431-55. [PubMed 20307191]\nDamm S. Intraoperative anaphylaxis associated with bacitracin irrigation. Am J Health-Syst Pharm. 2011;68(4):323-327. [PubMed 21289327]\nDudley MN, McLaughlin JC, Carrington G, et al, “Oral Bacitracin vs Vancomycin Therapy for Clostridium difficile-Induced Diarrhea. A Randomized Double-Blind Trial,” Arch Intern Med, 1986, 146(6):1101-4.\nElsner P, Pevny I, Burg G. Anaphylaxis induced by topically applied bacitracin. Am J Contact Dermat.1990;1:162-164.",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}